The association between diurnal blood pressure variation and diabetic nephropathy was assessed in four groups of Type 1 (insulin-dependent) diabetic patients who underwent 24-h ambulatory blood pressure monitoring using an oscillometric technique. Patients with nephropathy, who had never been treated for hypertension (group D3, n = 13), were individually matched for age, sex and diabetes duration to a group of microalbuminuric patients (D2, n = 26), to normoalbuminuric patients (DI, n = 26) and to healthy control subjects (C, n = 26). Group D3 was also compared to patients with advanced nephropathy receiving treatment for hypertension, mainly a combination of angiotensin converting enzyme inhibitors, metoprolot and diuretics (D~, n = 11). In group D3 24,h diastolic blood pressure (85 + 8 mmHg) was comparable to the results obtained in D4 (85 -1-8 mmHg) but significantly higher than in D2 (78 +7mmHg), D1 (73 + 7 mmHg) and C (73 + 7 mmHg, p < 0.05, Tukey's test). The night/day ratio of diastolic blood pressure was higher in D~ (86+5%) and D2 (85_+7%) than in C (80 + 7 % ,p < 0.02). This ratio was also elevated in group D4 (94 + 8 %) compared to D~ (p < 0.05) corresponding to a marked smoothing of the diurnal blood pressure curve. The 24-h heart rate (beats per rain) was significantly elevated in D3 (84 + 8) and D2 (80 _+ 10) compared with C (73 _+ 11, p < 0.05 Tukey's test), suggesting the presence of parasympathetic neuropathy. In conclusion the normal circadian variation of blood pressure was moderately disturbed in a group of microalbuminuric patients and patients with less advanced overt nephropathy. Patients with advanced diabetic nephropathy receiving antihypertensive therapy showed a marked reduction of nocturnal blood pressure fall, which can only be identified by the application of ambulatory blood pressure measurements to verify the 24-h effectiveness of blood pressure control.
Diabetic nephropathy is a severe complication which not only leads to premature death from renal failure [I] but is also strongly associated with increased cardiovascular mortality [2] . Antihypertensive treatment impedes progression of the disease [3, 4] and improves life expectancy [5] . Although a low-protein diet may be of added benefit [6] control of blood pressure remains the single most important treatment modality. Ambulatory 24-h blood pressure measurement is now a well-established technique which allows the physician to document the effectiveness of treatment during sleep and everyday activities [7] . Recent studies encompassing a combined population of Type 2 (non-insulin-dependent) and Type i (insulindependent) diabetic patients have demonstrated a blunted diurnal variation of blood pressure in patients suffering from diabetic autonomic neuropathy as defined by a battery of bedside tests [810] . The clinical significance of impaired reduction of nocturnal blood pressure may be of particular importance in diabetic nephropathy since a positive association exists between autonomic neuropathy and stages of renal disease [11] . We hypothesise that a similar association exists between stages of renal disease and loss of nocturnal blood pressure reduction.
Ambulatory blood pressure was studied in two groups of Type i diabetic patients with established diabetic nephropathy, one group receiving treatment and one group not receiving treatment for hypertension. Diabetic patients with normal urinary albumin excretion (UAE), patients with microalbuminuria, and healthy control subjects were included for comparison.
Subjects and methods
Type 1 diabetic patients were grouped by stage of renal disease using previously published cirteria [12] . The presence of diabetic nephropathy in patients who had never received antihypertensive or diuretic treatment (group D3, n = 13) was accepted if diabetes duration was more than t0 years and UAE was greater than 200 gg/min as well as the geometric mean in at least two of three timed overnight urine samples collected within 1 week. The patients in group D3 represent all those not taking antihypertensive treatment who regularly consult our out-patient clinic as well as the patients reintroduced to the clinic during a 2-year period. None of these patients were prescribed a low-protein diet. Each diabetic patient from group D3 was matched (without knowledge of blood pressure) for sex, age and diabetes duration to two microalbuminuric diabetic patients (group D2, n=26) (20 gg/min < UAE < 200 btg/min), two normoatbuminuric diabetic patients (group D1, n = 26) (UAE < 20 gg/min) and two healthy control subjects (group C, n =26). Patients and subjects in the matching groups had participated in a previously described study [13] .
A further group of patients with diabetic nephropathy taking antih}~ertensive treatment (group D4, n = 11) were also examined. Patients were included in this group if duration of antihypertensive treatment (median 52, range 12-132 months) was longer than I year and if hypertension was the indication for commencement of treatment according to the records i,e. diastolic blood pressure above 95 mmHg measured in the clinic by sphygmomanometer. One patient in group D3 was also included in D4 and restudied after 14 months of treatment for hypertension. As antihypertensive therapy we used angiotensin converting enzyme inhibitors (ACE-inhibitors) in combination with metoprotol and diuretics (n = 6), ACE-inhibitors in combination with diltiazem and diuretics (n =1), ACE-inhibitors in combination with diuretics (n = 3), and metoprolol combined with diuretics (n = 1). The ACE-inhibitors used were enalapril once per day, median dose 20 mg (range 5-20 mg) or captopril two times per day, total dose 75 mg (50-100 rag). Metoprolol was given at a total dose of 150 mg (50-200 mg) in the morning as a sustained-release preparation except in tow patients, one of whom received a standard preparation two times per day and one who received two dally doses of the sustained-release drug. Diuretics were thiazides (n = 4) dr furosemide (n ='7).
It is well-knoym that antihypertensive treatment in diabetic nephropathy may reduce UAE to a subclinical level and thus interferes with traditional criteria for diagnosing nephropathy [14] . One patient with elevated serum creatinine (171 gmol/I) and UAE of 59 btg/min was included in group D4. This patient had persistent albumin positive urine (Albustix, Ames, Bayer diagnostics, Bridgend, UK) at the initiation of antihypertensive therapy, and UAE was succesively reduced during the following 6 years while serum creatinine increased.
Twenty-four hour ambulatory blood pressure was measured oscillometrically by a portable lightweight monitor (Spacelabs 90202, Redmond, Wa, USA) fulfilling the standards of both the American Association for the Advancement of Medical Instruments and the British Hypertension Society [15] . The monitor was programmed to take measurements every 20 min during the day and every hour from 24.00 to 06.00 hours. Heart rate was measured as the frequency of oscillations in the cuff and thus recorded simultaneously with blood pressure. After the equipment was demonstrated in the laboratory, two measurements were activated to accustom the patient to the technique, and then three measurements were recorded with the patient sitting and the arm supported. The mean of these last three measurements is termed the clinic blood pressure. All five measurements obtained in the laboratory were deleted from the record before calculating 24 h blood pressures. Day mad night blood pressures and heart rates were calculated as the mean of hourly mean values based on each patient's self-recorded time for going to bed and rising in the morning.
UAE was measured by radioimmunoassay [16] , HbAI0 by high pressure liquid chromatography [17] and serum creatinine by a modificated Jaffds method on a SMAC-III autoanalyser (Technicon, Terrytown, NY, USA) using an end-point technique. Retinopathy was assessed by fundoscopy. Patients gave their informed consent and the study was approved by the local ethics committee.
Statistical analysis
Results for UAE were log transformed to obtain normal distribution before analysis and results are presented as geometric mean and tolerance factor. Group D3 was compared to the three matching groups by analysis of variance in cases of homogeneity of, variance (Bartlett's test). Non-continuous variables were compared by a rank sum test. Differences between groups were assessed by an unpaired 
Results
Groups D1, D2 and D3 were well-matched for age, sex and duration of diabetes (Table 1) . In addition HbAlc, insulin dose and body mass index were also comparable. Serum creatinine was significantly higher in D3 compared to D1 and D2. Two patients in D3 had a serum creatinine above the upper normal limit (120 gmoI/1) in our laboratory. Patients in group D4 were slightly older than those in D3 (41 + 9 vs 34 + 9 years), with longer diabetes duration (26 _+ 7 vs 21 +_ 7 years) and higher mean value of HbAic (9.5 _+ 1.3 vs 8.7 _+ 1.4 % ), however the differences did not reach the accepted level for statistical significance (p = 0.09, 0.08 and 0.17 respectively'). Retinopathy was more advanced in patients with nephropathy. Blood pressure results are given in Table 2 . Three patients in D3 but none in groups C, D1, or D2 had a diastolic clinic blood pressure above 95 mmHg. Both the clinic and ambulatory diastolic blood pressure was significantly higher in D3 than in groups C, D1 and Da (p < 0.05). Group D4 had clinic and ambulatory blood pressures comparable with D3.
The question of differences in diurnal variation of blood pressure was addressed by calculating the night/day ratio. Analysis of variance revealed significant (p < 0.05) inter-group differences for diastolic ratios which increased stepwise from C (79.8 + 7.4%) to D3 (86.0 _+ 5.1%). The intra-group variation however was high and when allowance for the correction for multiple testing was made no comparison between two groups was statistically significant. With comparison restricted to diabetic groups vs control subjects, disregarding correction for multiple testing, both D2 and D3 had a significantly higher diastolic night/day ratio than the control subjects (p = 0.01 for both). Systolic night/day ratios were not statistically significantly different by analysis of variance.
In De the night/day ratio of systolic and diastolic was significantly higher (97.6 _+ 8. The daytime heart rate increased gradually from C to D3, rendering groups D2 and D3 statistically different from C. During the night only heart rate in D3 was statistically significantly higher than in C (Table 2 and Fig.4 ). The heart rates (night or day) in D3 and D4 did not differ significantly. A multiple stepwise selection was performed in all diabetic patients (n = 76) with the diastolic night/day ratio as dependent variable and the following possible independent variables: diabetes duration, age, log (UAE), 1/serum creatinine, HbAlc, 24-h diastolic blood pressure, night heart rate and antihypertensive medication as a dichotomous variable (yes/no). The independent determinants selected were in order of significance: 1)24-h diastolic blood pressure, 2) night heart rate, 3) antihypertensive medication and 4) HbAlo (r 2 = 0.32,p < 0.0001 for the full regression).
Discussion
The present group of untreated patients with diabetic nephropathy are heavily biased towards a "normal" blood pressure since for the last 15 years much attention has been paid to nephropathic patients with the propose of early and effective antihypertensive treatment. Nevertheless, blood pressure in this group of patients was clearly elevated. This disappointing fact may partly be explained • Fig.3 . Individual night/day ratio for diastolic blood pressure in healthy control subjects and Type 1 (insulin-dependent) diabetic patients. C = control subjects (n = 26), D1 = normoalbuminuric patients (n = 26), D2 = microalbuminuric patients (n = 26), D3 = patients with diabetic nephropathy without antihypertensive treatment (n = 13), D4 = patients with diabetic nephropathy with antihypertensive treatment (n = 11). Horisontal lines indicate the range for control subjects by poor compliance by some of the patients who were not subjected to regular blood pressure control. Even if a treatment goal of a clinic blood pressure less than 140/90 mmHg was actually achieved in the treated group, this is still not considered normalization of blood pressure.
The diurnal blood pressure variation is expressed as the night/day ratio rather than night-day differences which a priori would overestimate the variation in hypertensive patients. A precise evaluation of the diurnal rhythm depends on accurate patient-reported night periods as used in this study. Compared to the nocturnal reduction of diastolic blood pressure in healthy subjects (C, 20 %) the study indicated a diminished reduction in the microalbuminuric group (D2, 15 %) and the diabetic nephropathy group with no antihypertensive treatment (D3, 14 %), although the differences did not reach statistical significance if correction for multiple comparision was applied [18] . In contrast the night reduction of diastolic blood pressure was 7 % in patients with diabetic nephropathy and treatment for hypertension (D4). In a study using the same equipment the relative night reduction of the diastolic blood pressure in healthy subjects was 14 %, whereas the reduction in a Type 1 diabetic population Circadian variation of blood pressure in diabetic nephropathy study found loss of the diurnal rhythm in patients specifically selected for the presence of autonomic neuropathy and absence of overt nephropathy [27] , suggesting that diabetic nephropathy is not a decisive factor for this abnormality of blood pressure variation. On the other hand a normal blood pressure pattern has been found in 28 % of patients with abnormal cardiovascular reflexes [8] and the prevalence of overt nephropathy was increased four-fold in a group of Type 2 diabetic patients with reversed circadian pattern [28] . Thus, both renal insufficiency and associated fluid retention, as well as autonomic dysfunction may be causually related to the disturbed circadian pattern in patients with advanced diabetic nephropathy. This hypothesis is supported by the results of the multiple stepwise selection from this study, which identified ambulatory blood pressure (itself strongly related to stages of renal disease) and indices of autonomic function (resting night heart rate) as independently influencing the night/day ratio of the diastolic blood pressure. In addition a rote for poor metabolic control is suggested. "Without withdrawal of medication it is not possible to fully evaluate the impact of the intensive antihypertensive treatment on the blunted diurnal variation of blood pressure. However, it is unlikely that the antihypertensive medication itself primarily induces an abnormal circadian pattern of 24.00 the blood pressure since this is unaffected in essential hypertension by both ACE-inhibitors and beta-blockers combined with diuretics [29, 30] . Moreover we have previously :reported night/day ratios in patients with early diabetic nephropathy treated with ACE-inhibitors, metoprolol and diuretics which are comparable to the values in the untreated group D3 ill the present study [31] . The independent prognostic significance of a blunted diurnal variation in diabetes is difficult to assess because the phenomenon seemingly goes hand in hand with diabetic nephropathy, itself heralding a poor prognosis. Moreover it is well-known that autonomic dysfunction determined by bedside testing [11, 32] or by 24-h assessment of vagal function [20] is more prevalent in patients with incipient or overt nephropathy. Autonomic cardiac dysfunction in diabetic patients has been related to an increased mortality mainly from renal failure [33] [34] [35] . It has been speculated that autonomic dysfunction could adversly affect renal function by promoting renal vasodilation and elevated transglomerular hydraulic pressure [36] . In this study, comparing two well-matched groups of insulin-treated diabetic patients with and without autonomic neuropaths; UAE was higher in the former group and significantly so only during the night [36] . The present study suggests the complementary theory, that the coexistence of nephropathy and autonomic neuropathy in addition to a poor metabolic control, could promote an abnormal elevated nocturnal blood pressure with a detrimental effect on renal function.
We conclude that a minor reduction of the diastolic nocturnal blood pressure fall is seen in Type I diabetic patients with microalbuminuria or early overt diabetic nephropathy and that major disturbances of the diurnal rhythm are present in the majority of patients with advanced diabetic nephropathy receiving treatment for hypertension. Ambulatory blood pressure monitoring of with different degrees of UAE was 3 % [19]. The night period was fixed from 22.00 hours to 06.00 hours regardless of when the individual patients actually slept which would tend to minimize the night/day ratio in both groups.
The presence of autonomic neuropathy in diabetic nephropathy in our study is suggested (but not proven by formal test of autonomic function) by the findings of elevated heart rates, most likely the effect of reduced vagat tone [20, 21] . Interestingly this difference when compared to control subjects is present not only in resting supine position at night, as expected because of the high nocturnal vagal tone in healthy subjects [20] , but also during upright position in the day. Such imbalance in cardiac innervation is associated with decreased heart rate variability and increased mortality after myocardial infarction, possibly by predisposing to fatal arrhythmias [22, 23] . This could explain the added beneficial effect of secondary prophylaxis with metoprolol after myocardial infarction in diabetic patients as compared to non-diabetic individuals [24, 25] . Against the background of high prevalence of ischaemic heart disease [26] in diabetic nephropathy and the very high cardiovascular mortality [2] the addition of beta1 blockers to treatment with ACE-inhibitors and diuretics may be fayourable for protection against unopposed sympathetic activity.
The cause of abnormal circadian blood pressure pattern in diabetes is most likely multifactorial. One previous antihypertensive treatment is necessary to achieve 24-h control of blood pressure without side effects.
